We are live on !
Find out more
CS McKee Portfolio holdings
AUM
$1.09B
Turnover
3.92%
1-Year Est. Return
31.33%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+31.33%
3 Year Est. Return
+47.55%
5 Year Est. Return
+66.61%
10 Year Est. Return
–
AUM
$1.09B
AUM Growth
-$12.3M
(-1.1%)
Cap. Flow
-$107M
Cap. Flow % of AUM
Cap. Flow %
-9.83%
Top 10 Holdings %
Top 10 Hldgs %
32.88%
Holding
102
New
2
Increased
26
Reduced
65
Closed
2
Avg Time Held
4.9
years
Top 10 Avg Time Held
3.1
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$9.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$8.6M |
| 3 |
Occidental Petroleum
OXY
|
+$2.05M |
| 4 |
Gilead Sciences
GILD
|
+$1.39M |
| 5 |
Freeport-McMoran
FCX
|
+$1.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$16M |
| 2 |
Kennametal
KMT
|
+$8.75M |
| 3 |
Apple
AAPL
|
+$7.48M |
| 4 |
Microsoft
MSFT
|
+$5.74M |
| 5 |
JPMorgan Chase
JPM
|
+$5.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.94% |
| 2 | Financials | 16.44% |
| 3 | Industrials | 13.05% |
| 4 | Healthcare | 12.6% |
| 5 | Communication Services | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Dick's Sporting Goods
DKS
$14.2B
| $17M | 1.56% |
343,702
-59,200
| -15% | -$2.52M |
2014 Q4
20 quarters
|
|
|
27
RTX Corp
RTX
$259B
| $16.7M | 1.53% |
177,110
+104,715
| +145% | +$9.5M |
2013 Q2
26 quarters
|
|
28
Starbucks
SBUX
$112B
| $16.4M | 1.5% |
186,580
-31,550
| -14% | -$2.69M |
2013 Q2
26 quarters
|
|
29
Expedia Group
EXPE
$35B
| $16.1M | 1.47% |
148,452
-12,500
| -8% | -$1.47M |
2016 Q1
15 quarters
|
|
30
Chevron
CVX
$440B
| $16M | 1.47% |
133,184
+7,950
| +6% | +$936K |
2013 Q2
26 quarters
|
|
31
Bank of New York Mellon
BNY
$96.6B
| $15.8M | 1.44% |
313,286
-32,700
| -9% | -$1.56M |
2013 Q2
26 quarters
|
|
32
BorgWarner
BWA
$11.9B
| $15.5M | 1.42% |
406,192
-34,477
| -8% | -$1.26M |
2013 Q2
26 quarters
|
|
33
Oracle
ORCL
$393B
| $15.3M | 1.4% |
289,459
-29,700
| -9% | -$1.63M |
2013 Q2
26 quarters
|
|
34
Norfolk Southern
NSC
$72.7B
| $15.2M | 1.39% |
78,150
-6,500
| -8% | -$1.22M |
2013 Q2
26 quarters
|
|
35
Alphabet (Google) Class A
GOOGL
$4.21T
| $14.9M | 1.36% |
222,400
-23,000
| -9% | -$1.48M |
2015 Q4
16 quarters
|
|
36
Marathon Petroleum
MPC
$133B
| $14.8M | 1.35% |
245,074
-41,250
| -14% | -$2.58M |
2014 Q4
20 quarters
|
|
37
Public Service Enterprise Group
PEG
$35B
| $14.5M | 1.33% |
245,708
-24,300
| -9% | -$1.47M |
2013 Q2
26 quarters
|
|
38
Celanese
CE
$5.25B
| $14.4M | 1.32% |
116,900
-18,600
| -14% | -$2.29M |
2018 Q2
6 quarters
|
|
39
Marriott International
MAR
$102B
| $14.4M | 1.32% |
95,000
-16,000
| -14% | -$2.14M |
2015 Q3
17 quarters
|
|
|
40
Occidental Petroleum
OXY
$62.7B
| $14.2M | 1.3% |
344,523
+51,055
| +17% | +$2.05M |
2013 Q2
26 quarters
|
|
41
American International
AIG
$42.2B
| $13.7M | 1.25% |
266,722
-24,200
| -8% | -$1.28M |
2013 Q2
26 quarters
|
|
42
DELISTED
Walgreens Boots Alliance
WBA
| $13.7M | 1.25% |
231,650
-18,600
| -7% | -$1.07M |
2013 Q2
26 quarters
|
|
43
F5
FFIV
$25.5B
| $11.6M | 1.06% |
83,100
-15,050
| -15% | -$2.12M |
2015 Q2
18 quarters
|
|
44
NextEra Energy
NEE
$163B
| $11.1M | 1.02% |
183,744
-21,800
| -11% | -$1.27M |
2013 Q2
26 quarters
|
|
|
45
Gilead Sciences
GILD
$190B
| $10.9M | 1% |
168,350
+21,350
| +15% | +$1.39M |
2014 Q2
22 quarters
|
|
46
Baker Hughes
BKR
$55.4B
| $9.9M | 0.91% |
386,500
-27,700
| -7% | -$630K |
2017 Q3
9 quarters
|
|
|
47
Bristol-Myers Squibb
BMY
$120B
| $9.6M | 0.88% |
+150,100
| New | +$8.6M |
2019 Q4
0 quarters
|
|
48
3M
MMM
$83.6B
| $8.94M | 0.82% |
60,577
-10,346
| -15% | -$1.45M |
2013 Q2
26 quarters
|
|
49
American Express
AXP
$214B
| $6.67M | 0.61% |
53,584
-7,400
| -12% | -$884K |
2013 Q2
26 quarters
|
|
50
Allstate
ALL
$62.4B
| $6.4M | 0.59% |
56,906
-7,100
| -11% | -$775K |
2013 Q2
26 quarters
|
|
Similar funds
TRAM
SC
KGACF
BPWA
CS McKee's Q4 2019 Portfolio in Review
As of Q4 2019, CS McKee held 102 positions worth $1.09B, down 1.1% from $1.11B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
CS McKee withdrew a net $107M in Q4 2019, closing 2 positions and reducing 65 holdings. Its most notable exit was Celgene Corp, an estimated $16M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
Against the trend, CS McKee opened a new position in Bristol-Myers Squibb worth $9.6M.
- CS McKee's largest Q4 2019 buy was Bristol-Myers Squibb: 150,100 shares worth $9.6M.
- CS McKee added most to RTX Corp in Q4 2019, an estimated $9.5M increase.
- CS McKee's biggest Q4 2019 reduction was Apple, cutting an estimated $7.48M.
- CS McKee fully exited Celgene Corp in Q4 2019, selling an estimated $16M.
- CS McKee's ten largest holdings make up 33% of its $1.09B portfolio in Q4 2019.
- CS McKee opened 2 new positions and closed 2 in Q4 2019.
- CS McKee's portfolio value fell 1.1% quarter-over-quarter to $1.09B.
Based on CS McKee's 13F filing for Q4 2019, filed 14 Feb 2020.